Table 3—

Change in lung function measures for single nucleotide polymorphisms from the CRP gene

AlleleFrequencyFEV1 mLFVC mLFEF25–75% mL
rs1205CC51.130 (reference)0 (reference)0 (reference)
TC39.85119.3 (-52.5–291.0)76.6 (-112.3–265.4)197.7 (-137.6–533.0)
TT9.02404.2 (109.4–699.1)368.8 (44.5–693.1)699.6 (123.9–1275.2)
rs1130864AA45.110 (reference)0 (reference)0 (reference)
AG42.86-138.8 (-319.5–41.9)-71.3 (-268.2–125.7)-299.9 (-651.0–51.2)
GG12.03-125.7 (-403.4–152.1)-86.0 (-388.7–216.8)-262.3 (-802.0–277.5)
rs1417938AA45.110 (reference)0 (reference)0 (reference)
TA42.11-140.3 (-321.8–41.2)-71.5 (-270.1–127.1)-301.4 (-653.4–50.7)
TT12.78-149.5 (-421.6–122.6)-125.3 (-423.0–172.4)-271.4 (-799.2–256.4)
rs3093068GG85.820 (reference)0 (reference)0 (reference)
GC+CC14.1837.5 (-206.4–281.4)58.1 (-206.8–323.0)-2.5 (-476.0–471.1)
rs1800947CC92.540 (reference)0 (reference)0 (reference)
GC7.46101.6 (-212.8–416.0)28.0 (-314.1–370.2)405.0 (-202.1–1012.1)
rs2794521CC48.510 (reference)0 (reference)0 (reference)
TC44.0317.8 (-156.0–191.5)28.4 (-161.0–217.8)-8.1 (-347.2–331.1)
TT7.46-279.5 (-605.8–46.9)-257.8 (-613.4–97.9)-422.8 (-1059.9–214.2)
rs3091244GG34.590 (reference)0 (reference)0 (reference)
GA+GT47.37-61.8 (-250.9–127.3)1.8 (-204.3–207.9)-224.6 (-591.7–142.4)
AA+AT+TT18.05-184.5 (-435.7–66.8)-138.0 (-411.8–135.8)-334.0 (-821.6–153.6)
  • Data are presented as per cent or coefficient (95% confidence interval) adjusted for age, sex, height, body mass index, unless otherwise stated. FEV1: forced expiratory volume in one second; FVC: forced vital capacity; FEF25–75%: mean forced expiratory flow between 25 and 75% of FVC.